For citations:
Ryabukhina Yu.E., Zeynalova P.A., Abbasbeyli F.M., Kupryshina N.A., Zhukov A.G., Timofeeva O.L., Valiev T.T. Use of daratumumab in combination with lenalidomide and dexamethasone (D-Rd regimen) in therapy of elderly patients with newly diagnosed multiple myeloma with high-risk cytogenetics. Clinical observation. MD-Onco. 2024;4(1):63-70. (In Russ.) https://doi.org/10.17650/2782-3202-2024-4-1-63-70
Email this article 